BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

154 related articles for article (PubMed ID: 32114514)

  • 41. Gynecological carcinosarcomas: Overview and future perspectives.
    Collet L; González López AM; Romeo C; Méeus P; Chopin N; Rossi L; Rowinski E; Serre AA; Rannou C; Buisson A; Treilleux I; Ray-Coquard I
    Bull Cancer; 2023 Nov; 110(11):1215-1226. PubMed ID: 37679206
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Carcinosarcoma of the uterus: immunohistochemical and genetic analysis of clonality of one case.
    Watanabe M; Shimizu K; Kato H; Imai H; Nakano H; Sugawa M; Shiraishi T
    Gynecol Oncol; 2001 Sep; 82(3):563-7. PubMed ID: 11520156
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Two Components of Variant Profiles in Primary Vaginal Carcinosarcoma via Next-Generation Sequencing and a Literature Review.
    Kotoku R; Yanazume S; Kuroda T; Kobayashi Y; Kitazono I; Akahane T; Tanimoto A; Kobayashi H
    Int J Surg Pathol; 2022 May; 30(3):288-294. PubMed ID: 34463147
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Microsatellite instability in uterine sarcomas.
    Amant F; Dorfling CM; Dreyer L; Vergote I; Lindeque BG; Van Rensburg EJ
    Int J Gynecol Cancer; 2001; 11(3):218-23. PubMed ID: 11437928
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Oncogene alterations in endometrial carcinosarcomas.
    Biscuola M; Van de Vijver K; Castilla MÁ; Romero-Pérez L; López-García MÁ; Díaz-Martín J; Matias-Guiu X; Oliva E; Palacios Calvo J
    Hum Pathol; 2013 May; 44(5):852-9. PubMed ID: 23199529
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Detection of PIK3CA E545A mutation in circulating tumor DNA of a patient affected by uterine carcinosarcoma.
    Fantappiè G; Malentacchi F; Turrini I; Sorbi F; Castiglione F; Vergoni F; Ammatuna C; Antonuzzo L; Fambrini M; Noci I; Pillozzi S
    Anticancer Drugs; 2020 Sep; 31(8):880-883. PubMed ID: 32796408
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Molecular evidence that most but not all carcinosarcomas of the uterus are combination tumors.
    Wada H; Enomoto T; Fujita M; Yoshino K; Nakashima R; Kurachi H; Haba T; Wakasa K; Shroyer KR; Tsujimoto M; Hongyo T; Nomura T; Murata Y
    Cancer Res; 1997 Dec; 57(23):5379-85. PubMed ID: 9393763
    [TBL] [Abstract][Full Text] [Related]  

  • 48. RNA-seq Identification of RACGAP1 as a Metastatic Driver in Uterine Carcinosarcoma.
    Mi S; Lin M; Brouwer-Visser J; Heim J; Smotkin D; Hebert T; Gunter MJ; Goldberg GL; Zheng D; Huang GS
    Clin Cancer Res; 2016 Sep; 22(18):4676-86. PubMed ID: 27121792
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Clinically relevant molecular subtypes and genomic alteration-independent differentiation in gynecologic carcinosarcoma.
    Gotoh O; Sugiyama Y; Takazawa Y; Kato K; Tanaka N; Omatsu K; Takeshima N; Nomura H; Hasegawa K; Fujiwara K; Taki M; Matsumura N; Noda T; Mori S
    Nat Commun; 2019 Oct; 10(1):4965. PubMed ID: 31672974
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Immunohistochemical survey of mismatch repair protein expression in uterine sarcomas and carcinosarcomas.
    Hoang LN; Ali RH; Lau S; Gilks CB; Lee CH
    Int J Gynecol Pathol; 2014 Sep; 33(5):483-91. PubMed ID: 25083964
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Landscape of somatic single-nucleotide and copy-number mutations in uterine serous carcinoma.
    Zhao S; Choi M; Overton JD; Bellone S; Roque DM; Cocco E; Guzzo F; English DP; Varughese J; Gasparrini S; Bortolomai I; Buza N; Hui P; Abu-Khalaf M; Ravaggi A; Bignotti E; Bandiera E; Romani C; Todeschini P; Tassi R; Zanotti L; Carrara L; Pecorelli S; Silasi DA; Ratner E; Azodi M; Schwartz PE; Rutherford TJ; Stiegler AL; Mane S; Boggon TJ; Schlessinger J; Lifton RP; Santin AD
    Proc Natl Acad Sci U S A; 2013 Feb; 110(8):2916-21. PubMed ID: 23359684
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Overexpression of Clostridium perfringens enterotoxin receptors claudin-3 and claudin-4 in uterine carcinosarcomas.
    Santin AD; Bellone S; Siegel ER; McKenney JK; Thomas M; Roman JJ; Burnett A; Tognon G; Bandiera E; Pecorelli S
    Clin Cancer Res; 2007 Jun; 13(11):3339-46. PubMed ID: 17545541
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Prognostic value of alternative lengthening of telomeres-associated biomarkers in uterine sarcoma and uterine carcinosarcoma.
    Lee YK; Park NH; Lee H
    Int J Gynecol Cancer; 2012 Mar; 22(3):434-41. PubMed ID: 22266933
    [TBL] [Abstract][Full Text] [Related]  

  • 54. PD-L1 Expression in Carcinosarcomas of the Gynecologic Tract: A Potentially Actionable Biomarker.
    Pinto A; Mackrides N; Nadji M
    Appl Immunohistochem Mol Morphol; 2018 Jul; 26(6):393-397. PubMed ID: 27801734
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Establishment and characterization of uterine sarcoma and carcinosarcoma patient-derived xenograft models.
    Cuppens T; Depreeuw J; Annibali D; Thomas D; Hermans E; Gommé E; Trinh XB; Debruyne D; Moerman P; Lambrechts D; Amant F
    Gynecol Oncol; 2017 Sep; 146(3):538-545. PubMed ID: 28625393
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Ovarian and uterine carcinosarcomas: a comparative analysis of prognostic variables and survival outcomes.
    Garg G; Shah JP; Kumar S; Bryant CS; Munkarah A; Morris RT
    Int J Gynecol Cancer; 2010 Jul; 20(5):888-94. PubMed ID: 20606539
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Transcriptional regulation of the alpha-1 type II collagen gene by nuclear factor B/p65 and Sox9 in the chondrocytic phenotype of uterine carcinosarcomas.
    Yoshida T; Hashimura M; Kuwata T; Matsumoto T; Suzuki E; Tazo Y; Nakajima H; Inukai M; Saegusa M
    Hum Pathol; 2013 Sep; 44(9):1780-8. PubMed ID: 23618358
    [TBL] [Abstract][Full Text] [Related]  

  • 58. The mutational repertoire of uterine sarcomas and carcinosarcomas in a Brazilian cohort: A preliminary study.
    da Costa LT; Dos Anjos LG; Kagohara LT; Torrezan GT; De Paula CAA; Baracat EC; Carraro DM; Carvalho KC
    Clinics (Sao Paulo); 2021; 76():e2324. PubMed ID: 33503190
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Expression profiles of carcinosarcoma of the uterine corpus-are these similar to carcinoma or sarcoma?
    Chiyoda T; Tsuda H; Tanaka H; Kataoka F; Nomura H; Nishimura S; Takano M; Susumu N; Saya H; Aoki D
    Genes Chromosomes Cancer; 2012 Mar; 51(3):229-39. PubMed ID: 22072501
    [TBL] [Abstract][Full Text] [Related]  

  • 60. ERBB2 gene as a potential therapeutic target in small bowel adenocarcinoma.
    Laforest A; Aparicio T; Zaanan A; Silva FP; Didelot A; Desbeaux A; Le Corre D; Benhaim L; Pallier K; Aust D; Pistorius S; Blons H; Svrcek M; Laurent-Puig P
    Eur J Cancer; 2014 Jul; 50(10):1740-1746. PubMed ID: 24797764
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.